Abstract
Background
Intermittent administration of parathyroid hormone (PTH) leads to bone formation by increasing osteoblast numbers and activity levels. Animal studies have shown that intermittent PTH administration increases implant fixation in normal rats. The purpose of this study was to analyze the osseous incorporation of an implant in osteoporotic rats while treating them with intermittent PTH (1–34) or alendronate.
Methods
A total of 36 ovariectomized (OVX) Wistar rats were randomized into three groups. Polymethylmethacrylate cement rods were implanted in one tibia in each rat. The three groups received daily PTH (60 μg/kg body weight [BW]), alendronate (200 μg/kg BW), or saline (0.5 ml/kg BW). A sham-ovariectomized group (n = 12) was treated with saline. After 2 weeks, the area around the implants was analyzed by histomorphometry for bone volume density (BVD) and implant bone contact. Bone mineral density (BMD) was evaluated by dual-energy X-ray absorptiometry.
Results
The BVD was higher in the specimens treated with PTH than in the other groups. PTH improved the BVD, BMD, and implant bone contact. Alendronate doubled the implant bone contact compared to the OVX and sham groups but did not improve BVD or BMD.
Conclusions
These findings confirm that intermittent PTH enhances implant fixation in osteoporotic bone. The clinical significance of these findings is that application of intermittent PTH may be beneficial for early implant fixation in fractures, nonunions, and prosthetic replacements when bone density is decreased.
Similar content being viewed by others
References
Kurth AH, Eberhardt C, Muller S, Steinacker M, Schwarz M, Bauss F. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone 2005;37:204–210.
Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg Br 2001;83:437–440.
Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 1999;14:960–968.
Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA. Parathyroid hormone enhances fracture healing: a preliminary report. Clin Orthop 1999:258–63.
Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 2002;17:2038–2047.
Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001;16:1846–1853.
Samnegard E, Iwaniec UT, Cullen DM, Kimmel DB, Recker RR. Maintenance of cortical bone in human parathyroid hormone (1–34)-treated ovariectomized rats. Bone 2001;28:251–260.
Skripitz R, Aspenberg P. Parathyroid hormone-a drug for orthopedic surgery? Acta Orthop Scand 2004;75:654–662.
Shirota T, Tashiro M, Ohno K, Yamaguchi A. Effect of intermittent parathyroid hormone (1–34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. J Oral Maxillofac Surg 2003;61:471–480.
Skripitz R, Bohling S, Ruther W, Aspenberg P. Stimulation of implant fixation by parathyroid hormone (1–34): a histomorphometric comparison of PMMA cement and stainless steel. J Orthop Res 2005;23:1266–1270.
Rogers M. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int 2004;75:451–461.
Amin D, Cornell SA, Gustafson SK, Needle SJ, Ullrich JW, Bilder GE, et al. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J Lipid Res 1992;33:1657–1663.
Morris CD, Einhorn TA. Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am 2005;87:1609–1618.
Eberhardt C, Habermann B, Muller S, Schwarz M, Bauss F, Kurth AH. The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model. J Orthop Sci 2007;12:61–66.
Eberhardt C, Schwarz M, Kurth AH. High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants. J Orthop Sci 2005;10:622–626.
Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, et al. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1–34) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Calcif Tissue Int 2006;79:262–272.
Skoglund B, Holmertz J, Aspenberg P. Systemic and local ibandronate enhance screw fixation. J Orthop Res 2004;22:1108–1113.
Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats. Exp Anim 2006;55:357–367.
Skripitz R, Aspenberg P. Parathyroid hormone (1–34) increases attachment of PMMA cement to bone. J Orthop Sci 2001;6:540–544.
Johansson HR, Skripitz R, Aspenberg P. Bisphosphonates can block the deterioration in implant fixation after withdrawal of intermittent doses of parathyroid hormone. J Bone Joint Surg Br 2008;90:400–404.
Seebach C, Skripitz R, Andreassen TT, Aspenberg P. Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 2004;22:472–478.
Skripitz R, Andreassen TT, Aspenberg P. Strong effect of PTH (1–34) on regenerating bone: a time sequence study in rats. Acta Orthop Scand 2000;71:619–624.
Skripitz R, Andreassen TT, Aspenberg P. Parathyroid hormone (1–34) increases the density of rat cancellous bone in a bone chamber: a dose-response study. J Bone Joint Surg Br 2000;82:138–141.
Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34). J Bone Joint Surg Am 2005;87:731–741.
Wermelin K, Suska F, Tengvall P, Thomsen P, Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone: histomorphometry in rats. Bone 2008;42:365–371.
Jensen TB, Bechtold JE, Chen X, Soballe K. Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants. J Orthop Res 2007;25:772–778.
Meraw SJ, Reeve CM. Qualitative analysis of peripheral periimplant bone and influence of alendronate sodium on early bone regeneration. J Periodontol 1999;70:1228–1233.
Meraw SJ, Reeve CM, Wollan PC. Use of alendronate in periimplant defect regeneration. J Periodontol 1999;70:151–158.
Kim HW, Jahng JS. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Iowa Orthop J 1999;19:71–77.
Author information
Authors and Affiliations
About this article
Cite this article
Skripitz, R., Johansson, H.R., Ulrich, S.D. et al. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci 14, 138–143 (2009). https://doi.org/10.1007/s00776-008-1311-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00776-008-1311-x